approv
aml
past
year
thu
discoveri
effect
therapeut
agent
need
aml
numer
herb
use
tradit
chines
medicin
may
great
valu
toona
sinensi
roem
meliacea
wide
distribut
asia
use
nutriti
food
long
time
edibl
leav
use
orient
medicin
signific
side
effect
treatment
enter
dysenteri
dermat
pharmacolog
biolog
activ
extract
toona
sinensi
ts
report
includ
anticanc
antioxid
antiatheroscleroticinflammatori
antidiabet
antiviru
well
inhibit
leydig
cell
steroidogenesi
sar
sever
acut
respiratori
syndrom
coronaviru
replic
phytochem
analys
ts
isol
triterpen
phenol
compound
fifteen
compound
ts
identifi
includ
methyl
gallat
gallic
acid
kaempferol
quercitin
quercitrin
ritin
catechin
epicatechin
oleic
acid
palmit
acid
linol
acid
linolen
acid
demonstr
phenol
acid
gallic
acid
major
compon
ts
leaf
extract
possess
antioxid
anticanc
activ
biolog
activ
compound
ts
extract
may
similar
natur
compound
phenol
compound
flavonoid
alkaloid
polysaccharid
glycoprotein
known
induc
cell
death
cancer
cell
safeti
level
nontox
characterist
ts
evalu
use
acut
subacut
toxic
studi
mice
rat
lethal
effect
found
concentr
high
gkg
bodi
weight
although
variou
bioactiv
studi
ts
carri
report
address
effect
ts
regul
immun
respons
antileukemia
activ
murin
leukemia
cell
studi
show
effect
ts
induct
apoptosi
cell
promot
immun
respons
antileukemia
activ
leukemia
balbc
mice
vivo
chemic
medium
obtain
gibco
brl
grand
island
ny
usa
antimous
bax
antimous
antirabbit
antirabbit
antirabbit
cytochrom
c
antibodi
purchas
santa
cruz
biotechnolog
inc
heidelberg
germani
chemic
highest
grade
commerci
avail
suppli
either
merck
darmstadt
germani
sigma
st
loui
mo
usa
cell
murin
myelomonocyt
leukem
cell
line
obtain
american
type
cultur
collect
rockvil
md
usa
cell
grown
supplement
heatinactiv
fb
mm
glutamin
penicillinstreptomycinneomycin
co
humidifi
incub
cultur
harvest
cell
number
enumer
hemocytomet
analysi
cell
suspens
leav
toona
sinensi
ts
sourc
fooyin
univers
kaohsiung
taiwan
voucher
specimen
character
dr
horngliang
lay
graduat
institut
biotechnolog
nation
pingtung
univers
scienc
technolog
pingtung
counti
taiwan
aqueou
extract
ts
prepar
ad
ml
water
g
leav
fresh
ts
boil
ml
remain
previous
describ
crude
extract
centrifug
rpm
minut
supernat
use
studi
crude
extract
g
concentr
vacuum
freez
dri
form
powder
stock
subsequ
store
subsequ
analysi
anticanc
properti
yield
ts
extract
effect
ts
cell
viabil
monitor
use
mtt
colorimetr
assay
brief
cellswel
plate
plate
pretreat
without
variou
concentr
ts
hour
treatment
cell
incub
mgml
mtt
phosphatebuff
salin
pb
hour
cultur
supernat
remov
resuspend
isopropanol
dissolv
mtt
formazan
absorb
measur
nm
use
enzymelink
immunosorb
assay
elisa
micropl
reader
effect
ts
cell
viabil
assess
percent
viabl
cell
compar
vehicletr
control
group
arbitrarili
assign
repres
viabil
assay
perform
triplic
concentr
doubl
stain
annexin
vfitc
pi
propidium
iodid
perform
estim
apoptot
rate
leukemia
cell
briefli
cell
incub
ts
hour
cell
trypsin
wash
twice
pb
centrifug
rpm
minut
cell
dish
suspend
bind
buffer
doublestain
annexin
vfitc
pi
minut
room
temperatur
result
green
fitc
red
pi
fluoresc
sampl
quantit
analyz
fac
calib
flow
cytomet
becton
dickinson
san
jose
ca
usa
cell
quest
softwar
obtain
result
interpret
follow
cell
neg
pi
cell
cell
seed
dish
cell
reach
confluenc
incub
without
indic
concentr
ts
hour
treat
cell
wash
cold
pb
suspend
lysi
buffer
mm
trishcl
ph
sucros
triton
mm
ethylenediamin
tetraacet
acid
edta
mm
dtt
mm
phenyl
methyl
sulfonyl
fluorid
suspens
vortex
kept
ice
minut
centrifug
g
minut
total
protein
content
quantifi
use
biorad
protein
assay
reagent
biorad
hercul
ca
usa
bovin
serum
albumin
bsa
standard
protein
extract
reconstitut
sampl
buffer
trishcl
sodium
dodecyl
sulfat
sd
glycerol
mixtur
boil
minut
equal
amount
denatur
protein
load
lane
separ
electrophoresi
sd
polyacrylamid
gel
protein
transfer
pvdf
polyvinylidin
fluorid
membran
overnight
membran
block
trisbuff
salin
contain
nonfat
dri
milk
minut
room
temperatur
incub
indic
primari
antibodi
hour
membran
incub
horseradish
peroxidaseconjug
goat
antirabbit
antimous
antibodi
hour
develop
use
chemiluminesc
substrat
millipor
billerica
usa
densitometr
analysi
band
intens
quantifi
use
commerci
avail
softwar
alpaeasefc
genet
technolog
inc
miami
fl
usa
total
male
balbc
mice
week
age
purchas
glyconex
inc
taiwan
maintain
cage
hous
specif
design
pathogenfre
isol
facil
lightdark
cycl
fed
rodent
chow
water
ad
libitum
experi
conduct
accord
guidelin
china
medic
univers
anim
ethic
research
board
balbc
mice
inject
cell
via
tail
vein
experi
carri
use
cell
less
passag
balbc
mice
divid
group
n
group
control
group
ii
inject
cell
group
iii
inject
cell
treat
ts
extract
mlmous
dissolv
pb
mgkg
everi
day
control
group
receiv
daili
inject
vehicl
day
treatment
anim
weigh
sacrif
blood
collect
anim
end
experi
hematolog
analysi
blood
sampl
ml
collect
anim
group
end
experi
treat
immedi
ammonium
chlorid
buffer
lyse
red
blood
cell
follow
centrifug
minut
rpm
isol
peripher
blood
mononuclear
cell
analyz
flow
cytometri
anim
control
experiment
group
weigh
whole
blood
drawn
tissu
liver
spleen
isol
weigh
anim
histopatholog
tissu
sampl
spleen
group
fix
formaldehyd
embed
paraffin
fivemillimet
section
stain
hematoxylin
eosin
describ
previous
result
vitro
vivo
experi
present
mean
standard
deviat
mean
sd
mean
standard
error
mean
se
respect
studi
data
analyz
use
analysi
varianc
anova
follow
dunnett
test
pairwis
comparison
statist
signific
defin
p
test
evalu
cell
viabil
human
leukemia
cancer
cell
cell
treat
variou
concentr
ts
hour
cell
surviv
evalu
mtt
assay
treatment
ts
cell
result
dosedepend
inhibit
cell
prolifer
ic
valu
figur
result
suggest
ts
cytotox
murin
leukemia
cell
next
determin
induct
apoptosi
cell
use
annexinvpi
stain
result
show
ts
treatment
result
signific
increas
late
apoptot
cell
wherea
signific
chang
necrot
cell
seen
figur
result
demonstr
ts
exert
cytotox
effect
leukemia
cell
via
induct
apoptot
cell
death
delin
manner
ts
induc
apoptosi
cell
mitochondriadepend
apoptot
protein
marker
examin
use
western
blot
analys
initi
level
cytochrom
c
cytosol
fraction
examin
result
indic
ts
treatment
hour
significantli
well
dosedepend
increas
protein
express
level
cytochrom
c
cytoplasm
figur
cytochrom
c
reportedli
involv
activ
downstream
caspas
trigger
apoptosi
investig
effect
cell
downstream
effector
cascad
cytochrom
c
includ
western
blot
analys
reveal
treatment
cell
ts
significantli
reduc
level
dosedepend
manner
figur
taken
togeth
data
suggest
tsinduc
apoptosi
cell
accompani
cytochrom
c
releas
activ
famili
protein
shown
play
import
regulatori
role
mitochondriamedi
apoptosi
either
activ
bax
bad
bok
inhibitor
bclxl
bclw
assess
whether
ts
promot
cell
death
due
induct
apoptosi
cell
investig
apoptosi
relat
protein
western
blot
shown
figur
antiapoptosi
protein
decreas
proapoptosi
protein
bax
increas
ts
treatment
hour
furthermor
ts
treatment
increas
ratio
cell
figur
result
indic
ts
may
disturb
bax
protein
ratio
induc
apoptosi
balbc
mice
inject
cell
via
tail
vein
treat
ts
mgkg
gavag
tube
week
anim
sacrif
examin
liver
spleen
tissu
individu
photograph
weigh
dissect
anim
shown
figur
day
treatment
inject
group
mice
exhibit
hind
leg
paralysi
bodi
curl
chang
hair
bright
decreas
mous
activ
wherea
ts
treat
group
decreas
paralysi
bodi
curl
improv
hair
bright
figur
weight
spleen
liver
present
figur
respect
inject
group
significantli
increas
weight
spleen
liver
compar
control
group
figur
due
metastasi
cell
toward
liver
spleen
increas
size
significantli
wherea
treatment
ts
mgkg
group
statist
decreas
weight
spleen
liver
tumorbear
mice
figur
histopatholog
result
suggest
tstreat
spleen
tissu
display
increas
megakaryocyt
decreas
number
neoplast
cell
neoplast
cell
contain
larg
irregular
nuclei
accompani
clump
chromatin
promin
nucleoli
abund
clear
light
eosinophil
cytoplasm
often
mitot
figur
also
note
mark
expans
red
pulp
littl
chang
white
pulp
seen
spleen
tissu
figur
result
hematolog
analysi
ts
treatment
shown
tabl
inject
group
show
signific
increas
white
blood
cell
wbc
count
compar
control
group
wherea
treatment
tstreat
group
dramat
decreas
wbc
count
compar
group
alon
furthermor
tstreat
group
increas
concentr
red
blood
cell
rbc
hemoglobin
hb
hematocrit
hct
mean
corpuscular
volum
mcv
level
compar
group
alon
contrast
ts
treatment
reduc
concentr
mean
corpuscular
hemoglobin
mch
mch
concentr
mchc
level
result
indic
ts
antileukemia
capac
promot
immun
respons
bear
mice
vivo
determin
effect
ts
leukocyt
differenti
lymphocyt
neutrophil
monocyt
eosinophil
basophil
nucleat
rbc
analyz
shown
tabl
tstreat
group
significantli
decreas
express
lymphocyt
compar
alon
group
contrast
eosinophil
shown
statist
decreas
compar
control
inject
mice
observ
chang
eosinophil
could
due
excess
product
steroid
natur
chemic
produc
bodi
releas
blood
furthermor
segment
neutrophil
increas
inject
tstreat
group
compar
control
inject
group
increas
nucleat
rbc
count
wherea
tstreat
group
decreas
express
rbc
level
tabl
well
known
mani
natur
compound
food
plant
chemoprevent
chemotherapeut
efficaci
human
cancer
number
natur
product
isol
chines
herb
found
induc
apoptosi
suppress
angiogenesi
inhibit
prolifer
retard
metastasi
enhanc
chemotherapi
exhibit
anticanc
potenti
vitro
vivo
differ
compon
given
herb
may
synergist
activ
offer
greater
therapeut
prevent
activ
combin
previou
studi
demonstr
aqueou
extract
ts
gallic
acid
promot
apoptosi
human
premyelocyt
leukemia
cell
verifi
possibl
anticanc
effect
ts
first
step
toward
develop
novel
put
anticanc
agent
investig
capac
inhibit
murin
leukemia
cell
growth
associ
immun
respons
cell
inject
via
tail
vein
mice
model
leukem
anim
use
explor
anticanc
agent
low
cost
promot
short
time
develop
antileukem
agent
vivo
result
indic
ts
significantli
inhibit
cell
induc
apoptosi
mitochondri
death
pathway
vitro
immun
respons
vivo
mitochondri
death
pathway
control
member
protein
class
proapoptot
bax
protein
protooncogen
antagon
apoptosi
mani
cancer
contrari
overexpress
bax
acceler
apoptot
death
loss
mitochondri
membran
potenti
induc
cytochrom
c
releas
mitochondria
cytoplasm
lead
activ
downstream
cleavag
main
effector
executor
caspas
involv
apoptosi
play
pivot
role
disintegr
cell
undergo
apoptosi
find
show
tsinduc
apoptosi
associ
downregul
upregul
bax
murin
cell
chang
protein
disrupt
mitochondria
membran
permeabl
releas
cytochrom
c
cytosol
lead
apoptosi
via
caspas
activ
figur
immun
system
vital
defens
cancer
growth
tumor
infecti
diseas
adjust
immun
respons
allevi
diseas
great
interest
sever
year
recent
sever
medicin
plant
product
use
modul
immun
respons
furthermor
immunomodul
induc
medicin
plant
provid
potenti
altern
convent
chemotherapi
variou
diseas
especi
host
defens
mechan
need
activ
condit
impair
immun
respons
leukemia
type
cancer
bone
marrow
cell
produc
white
blood
cell
leukocyt
immun
system
cell
undergo
neoplasia
transform
cell
uncondit
produc
abnorm
amount
wbc
mainli
immatur
form
neoplast
cell
crowd
cell
marrow
lead
decreas
product
red
cell
platelet
line
wbc
destruct
aspect
diseas
often
exhibit
lack
cell
type
lead
format
hemorrhag
anemia
importantli
intern
organ
liver
spleen
bulg
increas
white
cell
furthermor
leukem
cell
markedli
reduc
immun
function
lead
excess
incid
infect
vivo
model
mice
inject
well
establish
murin
monomyelocyt
leukemia
cell
deriv
balbc
mous
use
ideal
system
studi
potenti
anticanc
agent
effect
ts
vivo
tumor
cell
balbc
mice
also
examin
select
mgkg
ts
vivo
studi
base
pretest
data
shown
result
indic
ts
significantli
decreas
weight
liver
spleen
examin
anim
figur
notabl
reason
use
model
elev
peripher
monocyt
granulocyt
immatur
morpholog
caus
enlarg
infiltr
spleen
compar
normal
group
also
number
white
blood
cell
increas
inject
group
decreas
tstreat
group
experi
indic
spleen
liver
size
decreas
decreas
white
blood
cell
tstreat
group
recruit
leukocyt
toward
stimuli
great
signific
product
effect
immun
respons
recent
studi
show
leukocyt
valu
rais
increas
malign
cancer
cell
previou
literatur
suggest
ts
exhibit
antiinflammatori
potenti
vitro
vivo
regul
immun
system
process
physiolog
respons
inflammatori
stimuli
antiinflammatori
effect
ts
involv
suppress
lpsinduc
product
serum
organ
mice
present
studi
tstreat
group
reduc
level
leukocyt
show
ts
promot
immun
respons
balbc
mice
exhibit
antileukemia
activ
toward
murin
cell
natur
product
includ
plant
provid
rich
resourc
anticanc
drug
discoveri
differ
compon
given
herb
may
buffer
toxic
effect
offer
synergist
activ
extract
mixtur
herb
may
offer
greater
therapeut
prevent
activ
combin
previou
studi
number
compound
includ
gallic
acid
methyl
gallat
ethyl
gallat
kaempferol
quercetin
quercitrin
rutin
isol
leav
ts
verifi
hplc
analog
inform
report
literatur
total
phenol
content
ts
estim
mg
gallic
acid
equivalentsg
plant
extract
yield
gallic
acid
natur
phenol
compon
purifi
ts
approxim
although
remain
unclear
compon
ts
activ
compound
polyphenol
receiv
increas
attent
recent
interest
new
find
regard
biolog
activ
compound
demonstr
gallic
acid
possess
antioxid
anticanc
activ
gallic
acid
structur
relat
compound
main
phenol
compon
black
green
tea
red
wine
studi
found
gallic
acid
induc
apoptosi
cancer
cell
hela
kb
cell
higher
sensit
normal
analog
rat
primari
cultur
hepatocyt
macrophag
endotheli
cell
fibroblast
studi
shown
gallic
acid
caus
inactiv
phosphoryl
lead
cell
cycl
arrest
apoptosi
induct
human
prostat
carcinoma
du
cell
current
work
ts
exhibit
antileukem
potenti
might
due
presenc
flavonoid
polyphenol
gallic
acid
howev
isol
structur
character
activ
constitu
necessari
extrapol
mechan
action
taken
togeth
result
confirm
potenti
toona
sinensi
agent
chemotherapeut
murin
myelocyt
leukemia
cell
vitro
vivo
find
also
sustain
content
sinensi
may
possess
anticanc
properti
potenti
valuabl
applic
food
drug
product
howev
vivo
studi
use
anim
model
necessari
elabor
exploit
nascent
promis
